Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


Articles published in J Nephrol

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    March 2021
  1. PICCOLI GB
    A sad anniversary, one year of COVID-19 epidemics-in this issue: from COVID-19 to membranous nephropathy.
    J Nephrol. 2021 Mar 26. pii: 10.1007/s40620-021-01031.
    PubMed    


  2. GENTILE M, Rossi GM, Delsante M, Zambrano C, et al
    Atypical hemolytic uremic syndrome complicating relapsing cryoglobulinemic membranoproliferative glomerulonephritis despite hepatitis C eradication.
    J Nephrol. 2021 Mar 17. pii: 10.1007/s40620-021-00998.
    PubMed    


  3. GOMES MF, Mardones C, Xipell M, Blasco M, et al
    The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis.
    J Nephrol. 2021 Mar 15. pii: 10.1007/s40620-021-01007.
    PubMed     Abstract available


  4. ALKHATIB MH, Kant S, Menez S, Lakhani L, et al
    Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus.
    J Nephrol. 2021 Mar 10. pii: 10.1007/s40620-021-01010.
    PubMed     Abstract available


  5. HAMROUN A, Lenain R, Gibier JB, Maanaoui M, et al
    Nephrology picture: intraglomerular metastases, an exceptional cause of glomerulonephritis.
    J Nephrol. 2021 Mar 9. pii: 10.1007/s40620-021-00999.
    PubMed    


    February 2021
  6. TANG C, Lv JC, Shi SF, Chen YQ, et al
    Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2021 Feb 16. pii: 10.1007/s40620-021-00988.
    PubMed     Abstract available


  7. STRUFALDI FL, Menezes Neves PDMM, Dias CB, Yu L, et al
    Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis.
    J Nephrol. 2021 Feb 11. pii: 10.1007/s40620-020-00938.
    PubMed     Abstract available


  8. KANT S, Morris A, Ravi S, Floyd L, et al
    The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.
    J Nephrol. 2021;34:185-190.
    PubMed     Abstract available


    January 2021
  9. HOGAN JJ, Zee J, Beck LH
    Towards optimizing use of PLA2R antibody testing in membranous nephropathy.
    J Nephrol. 2021 Jan 27. pii: 10.1007/s40620-021-00971.
    PubMed    


  10. DOMINGUEZ B, Vigo R
    Hypocomplementemic urticarial vasculitis syndrome associated with rapidly progressive glomerulonephritis: lessons for the clinical nephrologist.
    J Nephrol. 2021 Jan 12. pii: 10.1007/s40620-020-00942.
    PubMed    


  11. LIU MY, Wang SX, Dong Y, Zhou FD, et al
    Pregnancy-associated proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    J Nephrol. 2021 Jan 4. pii: 10.1007/s40620-020-00894.
    PubMed     Abstract available


  12. OTO OA, Demir E, Mirioglu S, Dirim AB, et al
    Clinical significance of glomerular C3 deposition in primary membranous nephropathy.
    J Nephrol. 2021 Jan 2. pii: 10.1007/s40620-020-00915.
    PubMed     Abstract available


    December 2020
  13. EDER M, Kozakowski N, Omic H, Aigner C, et al
    Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival.
    J Nephrol. 2020 Dec 11. pii: 10.1007/s40620-020-00914.
    PubMed     Abstract available


    October 2020
  14. PORCELLI B, Guarnieri A, Ferretti F, Garosi G, et al
    Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience.
    J Nephrol. 2020 Oct 29. pii: 10.1007/s40620-020-00888.
    PubMed     Abstract available


  15. SCHMIDT T, Schulze M, Harendza S, Hoxha E, et al
    Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab.
    J Nephrol. 2020 Oct 7. pii: 10.1007/s40620-020-00874.
    PubMed     Abstract available


    August 2020
  16. LENNARTZ DP, Seikrit C, Wied S, Fitzner C, et al
    Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy.
    J Nephrol. 2020 Aug 27. pii: 10.1007/s40620-020-00836.
    PubMed     Abstract available


  17. PEREZ-HERNANDEZ J, Martinez-Arroyo O, Ortega A, Galera M, et al
    Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis.
    J Nephrol. 2020 Aug 16. pii: 10.1007/s40620-020-00832.
    PubMed     Abstract available


  18. WANG R, Wang M, Xia Z, Gao C, et al
    Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases.
    J Nephrol. 2020 Aug 8. pii: 10.1007/s40620-020-00816.
    PubMed     Abstract available


    July 2020
  19. ANGELETTI A, Leventhal JS, Cravedi P
    Membranous nephropathy: setting the bar for hypothesis-driven, selective therapies in nephrology.
    J Nephrol. 2020 Jul 18. pii: 10.1007/s40620-020-00806.
    PubMed    


    June 2020
  20. FENOGLIO R, Baldovino S, Sciascia S, De Simone E, et al
    Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy.
    J Nephrol. 2020 Jun 27. pii: 10.1007/s40620-020-00781.
    PubMed     Abstract available


  21. LIANG S, Chen D, Liang D, Xu F, et al
    Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.
    J Nephrol. 2020 Jun 18. pii: 10.1007/s40620-020-00783.
    PubMed     Abstract available


  22. PONTICELLI C, Doria A, Moroni G
    Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases).
    J Nephrol. 2020 Jun 11. pii: 10.1007/s40620-020-00772.
    PubMed     Abstract available


  23. TAO T, Wang J, Lei S, Hu Z, et al
    Identical twins with idiopathic membranous nephropathy.
    J Nephrol. 2020 Jun 10. pii: 10.1007/s40620-020-00770.
    PubMed     Abstract available


  24. WU H, Fang X, Xia Z, Gao C, et al
    Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    J Nephrol. 2020 Jun 7. pii: 10.1007/s40620-020-00767.
    PubMed     Abstract available


    May 2020
  25. PONTICELLI C, Podesta MA
    Calcineurin inhibitors in lupus nephritis.
    J Nephrol. 2020 May 27. pii: 10.1007/s40620-020-00757.
    PubMed    


  26. ARGOLINI LM, Frontini G, Elefante E, Saccon F, et al
    Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
    J Nephrol. 2020 May 27. pii: 10.1007/s40620-020-00753.
    PubMed     Abstract available


  27. MA F, Yang X, Zhou M, Bai M, et al
    Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    J Nephrol. 2020 May 23. pii: 10.1007/s40620-020-00752.
    PubMed     Abstract available


  28. ZHANG J, Mi Y, Zhou R, Liu Z, et al
    The TLR4-MyD88-NF-kappaB pathway is involved in sIgA-mediated IgA nephropathy.
    J Nephrol. 2020 May 9. pii: 10.1007/s40620-020-00722.
    PubMed     Abstract available


    April 2020
  29. COPPO R, Robert T
    IgA nephropathy in children and in adults: two separate entities or the same disease?
    J Nephrol. 2020 Apr 20. pii: 10.1007/s40620-020-00725.
    PubMed     Abstract available


    March 2020
  30. VAN KRUIJSDIJK RCM, Abrahams AC, Nguyen TQ, Minnema MC, et al
    Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.
    J Nephrol. 2020 Mar 27. pii: 10.1007/s40620-020-00723.
    PubMed     Abstract available


    February 2020
  31. HU X, Feng J, Deng S, Tang J, et al
    Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy.
    J Nephrol. 2020 Feb 8. pii: 10.1007/s40620-020-00708.
    PubMed     Abstract available


    January 2020
  32. BINDA V, Trezzi B, Del Papa N, Beretta L, et al
    Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient).
    J Nephrol. 2020 Jan 30. pii: 10.1007/s40620-020-00706.
    PubMed     Abstract available


  33. SCIASCIA S, Radin M, Cecchi I, Fenoglio R, et al
    Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis.
    J Nephrol. 2020 Jan 23. pii: 10.1007/s40620-019-00698.
    PubMed     Abstract available


    December 2019
  34. XU BY, Meng SJ, Shi SF, Liu LJ, et al
    MicroRNA-21-5p participates in IgA nephropathy by driving T helper cell polarization.
    J Nephrol. 2019 Dec 20. pii: 10.1007/s40620-019-00682.
    PubMed     Abstract available


    September 2019
  35. CIFERSKA H, Honsova E, Lodererova A, Hruskova Z, et al
    Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
    J Nephrol. 2019 Sep 5. pii: 10.1007/s40620-019-00640.
    PubMed     Abstract available


    November 2018
  36. REYNOLDS ML, Nachman PH, Mooberry MJ, Crona DJ, et al
    Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy.
    J Nephrol. 2018 Nov 12. pii: 10.1007/s40620-018-0552.
    PubMed     Abstract available


    September 2018
  37. TAMPOIA M, Migliucci F, Villani C, Abbracciavento L, et al
    Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.
    J Nephrol. 2018 Sep 5. pii: 10.1007/s40620-018-0533.
    PubMed     Abstract available


    April 2018
  38. L'IMPERIO V, Pieruzzi F, Sinico RA, Nebuloni M, et al
    Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    J Nephrol. 2018 Apr 6. pii: 10.1007/s40620-018-0489.
    PubMed     Abstract available


    March 2018
  39. MILILLO A, Molinario C, Costanzi S, Vischini G, et al
    Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schonlein purpura.
    J Nephrol. 2018 Mar 1. pii: 10.1007/s40620-018-0482.
    PubMed     Abstract available


    December 2017
  40. CHEN D, Hu W
    Lupus podocytopathy: a distinct entity of lupus nephritis.
    J Nephrol. 2017 Dec 22. pii: 10.1007/s40620-017-0463.
    PubMed     Abstract available


    November 2017
  41. XU K, Zhang L, Ding J, Wang S, et al
    Value of the Oxford classification of IgA nephropathy in children with Henoch-Schonlein purpura nephritis.
    J Nephrol. 2017 Nov 28. pii: 10.1007/s40620-017-0457.
    PubMed     Abstract available


    October 2017
  42. RADICE A, Pieruzzi F, Trezzi B, Ghiggeri G, et al
    Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    J Nephrol. 2017 Oct 28. doi: 10.1007/s40620-017-0451.
    PubMed     Abstract available


    September 2017
  43. ANGIOI A, Lepori N, Lopez AC, Sethi S, et al
    Treatment of primary membranous nephropathy: where are we now?
    J Nephrol. 2017 Sep 5. doi: 10.1007/s40620-017-0427.
    PubMed     Abstract available


    February 2017
  44. LUAN JJ, Xing GQ
    Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.
    J Nephrol. 2017;30:63-71.
    PubMed     Abstract available


  45. GEETHA D, Lee SM, Shah S, Rahman HM, et al
    Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis.
    J Nephrol. 2017;30:147-153.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: